Osphena, a new FDA-approved drug by Shionogi, Inc. is guaranteeing better sex to more than 64 million women in the United States and is headed to the market this June.
The drug, which mimics estrogen, is marketed toward women who hit menopause as the answer to painful sex. Some call it a milestone in women’s menopause therapies, while some critics think it's completely propagandizing female sexual dysfunction.
Our friends at The Daily Beast take a close look into the drug and the company's campaign, asking whether the pill will bring more pleasure to women or to the pharmaceutical industry.
Read the article at The Daily Beast: Will This Pill Fix Your Sex Life?
More from The Daily Beast: